Neogen Corporation specializes in developing and marketing products for food and animal safety. Its core offerings include diagnostic tests, food safety solutions, and veterinary pharmaceuticals. The company operates primarily in two segments: Food Safety and Animal Safety. Major revenue sources stem from sales of diagnostic kits, pathogen detection systems, and veterinary products. Neogen serves various markets, including food manufacturers, agricultural producers, and veterinary clinics.
The investment profile of Neogen Corporation is more aligned with balanced investors, given its focus on stable revenue growth and potential for future profitability. The absence of dividends suggests a reinvestment strategy, appealing to those seeking growth. The company's moderate risk and potential for appreciation may attract investors with a medium to long-term horizon.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-10-07 | Hold | Sell | Weak fundamentals and negative momentum signal high risk. |
| 2026-09-12 | Sell | Hold | Weak fundamentals and high risk limit upside potential. |
| 2026-09-04 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-08-27 | — | Hold | Weak fundamentals and high risk limit upside potential. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-09-30 | Guggenheim | Target Raised | 12 → 14 | 12.73 |
| 2026-08-03 | Piper Sandler | Target Raised | 11 → 13 | 12.04 |
| 2026-01-12 | Piper Sandler | Target Raised | 6.5 → 10 | 9.27 |
| 2026-01-09 | Guggenheim | Target Raised | 8 → 12 | 9.71 |
| 2025-10-16 | Piper Sandler | Target Raised | 5 → 6.5 | 5.95 |
